MedPath

Changes in heart rate and immediate blood pressure and after different protocols of breathing exercises in patients with Chagas' heart disease.

Not Applicable
Conditions
Chagas' disease (chronic) with heart involvement
B57.2
Registration Number
RBR-6qw5sp
Lead Sponsor
Instituto Nacional de Infectologia Evandro Chagas
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Male and female gender; be over 18 years old; having stage B2 and C chagasic heart disease; be in regular follow-up at the Chagas disease outpatient clinic of the Evandro Chagas National Institute of Infectious Diseases (INI).

Exclusion Criteria

Clinically decompensated individuals; who have chronic lung disease; who have atrial fibrillation; pacemaker carriers; who present some clinical limitation that contraindicates the performance of the proposed exercise protocol; pregnant women.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A greater reduction in systolic, diastolic and mean blood pressure, as measured by plethysmography, is expected immediately after and within 60 minutes after the respiratory muscle training maneuver comparing the difference between the strength protocol group to the the endurance protocol group.
Secondary Outcome Measures
NameTimeMethod
A greater increase in heart rate, as measured using a cardiofrequencimeter, is expected immediately after and within 60 minutes after the respiratory muscle training maneuver comparing the difference between the strength protocol group to the the endurance protocol group.;A greater increase in myocardial work, stimated by doble-product (measured by the multiplication of systolic blood pressure by heart rate), is expected immediately after and within 60 minutes after the respiratory muscle training maneuver comparing the difference between the strength protocol group to the the endurance protocol group.
© Copyright 2025. All Rights Reserved by MedPath